Gyro Medisys Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
About Gyro Medisys
Gyro Medisys Private Limited (GMPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2022 (Two years and seven months 0 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Ganesh Prajapati, Priti Goyal, Vimla Gupta, and One other member serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33119RJ2022PTC082881
- Company No.
082881
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2022
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Gyro Medisys?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Prajapati  | Director | 06-Oct-2023 | Current |
| Priti Goyal | Director | 01-Apr-2024 | Current |
| Vimla Gupta | Director | 28-Jul-2022 | Current |
| Vinita Prajapati | Director | 28-Jul-2022 | Current |
Financial Performance of Gyro Medisys.
Gyro Medisys Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gyro Medisys?
Unlock access to Gyro Medisys's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 0.40 Cr
- Others : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2024 | Yes Bank Limited | ₹4.00 M | Open |
| 02 Apr 2024 | Others | ₹3.00 M | Open |
How Many Employees Work at Gyro Medisys?
Gyro Medisys has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gyro Medisys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gyro Medisys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.